BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30722942)

  • 1. Oocyte quantity and quality are crucial for a perspective of fertility preservation in women with Turner syndrome.
    Borini A; Coticchio G
    Fertil Steril; 2019 Mar; 111(3):461-462. PubMed ID: 30722942
    [No Abstract]   [Full Text] [Related]  

  • 2. Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure.
    Oktay K; Rodriguez-Wallberg KA; Sahin G
    Fertil Steril; 2010 Jul; 94(2):753.e15-9. PubMed ID: 20188362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility Preservation in Women with Turner Syndrome: A Comprehensive Review and Practical Guidelines.
    Oktay K; Bedoschi G; Berkowitz K; Bronson R; Kashani B; McGovern P; Pal L; Quinn G; Rubin K
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):409-416. PubMed ID: 26485320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of oocyte cryopreservation for fertility preservation in patients with sex chromosome disorders: a case series describing outcomes.
    Martel RA; Blakemore JK; Fino ME
    J Assist Reprod Genet; 2022 May; 39(5):1143-1153. PubMed ID: 35320443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To Freeze or Not to Freeze? An Update on Fertility Preservation In Females with Turner Syndrome.
    Schleedoorn MJ; van der Velden AAEM; Braat DDM; Peek R; Fleischer K
    Pediatr Endocrinol Rev; 2019 Mar; 16(3):369-382. PubMed ID: 30888127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic.
    El-Shawarby SA; Sharif F; Conway G; Serhal P; Davies M
    BJOG; 2010 Jan; 117(2):234-7. PubMed ID: 20002398
    [No Abstract]   [Full Text] [Related]  

  • 7. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turner syndrome: fertility counselling in childhood and through the reproductive lifespan.
    Bollig KJ; Mainigi M; Senapati S; Lin AE; Levitsky LL; Bamba V
    Curr Opin Endocrinol Diabetes Obes; 2023 Feb; 30(1):16-26. PubMed ID: 36437755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report.
    Gidoni YS; Takefman J; Holzer HE; Elizur SE; Son WY; Chian RC; Tan SL
    Fertil Steril; 2008 Nov; 90(5):2008.e9-12. PubMed ID: 18692829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oocyte cryopreservation in a woman with mosaic Turner syndrome: a case report.
    Kavoussi SK; Fisseha S; Smith YR; Smith GD; Christman GM; Gago LA
    J Reprod Med; 2008 Mar; 53(3):223-6. PubMed ID: 18441731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical clinical aspects of oocyte vitrification for fertility preservation].
    Courbiere B; Decanter C
    Gynecol Obstet Fertil; 2014 Sep; 42(9):653-6. PubMed ID: 25164159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation utilizing controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Stoop D; De Vos M; Tournaye H; Devroey P
    Fertil Steril; 2012 Nov; 98(5):1121-2. PubMed ID: 22883568
    [No Abstract]   [Full Text] [Related]  

  • 14. Female fertility preservation in DSD.
    Kalra R; Cameron M; Stern C
    Best Pract Res Clin Endocrinol Metab; 2019 Jun; 33(3):101289. PubMed ID: 31331728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of fertility and oocyte genetics in a young woman with mosaic Turner syndrome.
    Balen AH; Harris SE; Chambers EL; Picton HM
    BJOG; 2010 Jan; 117(2):238-42. PubMed ID: 20002399
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: Case Report.
    Huang JY; Tulandi T; Holzer H; Lau NM; Macdonald S; Tan SL; Chian RC
    Hum Reprod; 2008 Feb; 23(2):336-9. PubMed ID: 18056118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LETTER TO THE EDITOR Re: First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome.
    Bamba V; Levitsky LL; Wong AW; Rivera-Cruz G; Scurlock C; Lin AE
    J Assist Reprod Genet; 2022 Mar; 39(3):777-778. PubMed ID: 35312935
    [No Abstract]   [Full Text] [Related]  

  • 20. Fertility preservation in women with borderline ovarian tumours.
    Mangili G; Somigliana E; Giorgione V; Martinelli F; Filippi F; Petrella MC; Candiani M; Peccatori F
    Cancer Treat Rev; 2016 Sep; 49():13-24. PubMed ID: 27428850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.